Home › Alpha-1 Antitrypsin Deficiency › Alabama › Birmingham
Alpha-1 Antitrypsin Deficiency clinical trials in Birmingham, AL
5 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RecruitingPhase 3
- GC2501 Study Site 106, Birmingham
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
RecruitingPhase 3
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
RecruitingPhase 1/2
- Clinical Study Center, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
RecruitingObservational study
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
RecruitingPhase 4
- University of Alabama at Birmingham, Birmingham
About Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency is an inherited condition that raises your risk for lung and liver disease. Learn about the symptoms and treatment.
More about Alpha-1 Antitrypsin Deficiency on MedlinePlus
Alpha-1 Antitrypsin Deficiency trials in other cities
- Charleston, SC6 studies
- Gainesville, FL6 studies
- Boston, MA4 studies
- Rochester, MN4 studies
- New York City, NY4 studies
- Cleveland, OH3 studies
- Los Angeles, CA3 studies
- Phoenix, AZ3 studies
- Miami, FL3 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Obesity24 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD18 studies
- Overweight17 studies
- Cardiovascular Disease17 studies
- Endometrial Cancer16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.